当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析

天坛生物

(600161)

  

流通市值:376.29亿  总市值:376.29亿
流通股本:19.77亿   总股本:19.77亿

天坛生物(600161)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润8.66亿元,每股收益0.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1499013.80万元,未分配利润684533.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1652181.70万元,负债153167.91万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,110,392,965.341,317,766,404.916,031,865,460.164,073,361,821.56
营业总成本2,079,476,311.38908,034,937.263,517,680,781.422,397,917,802.96
其他经营收益
营业利润1,041,961,680.23406,247,067.262,557,785,310.271,726,594,718.67
利润总额1,038,370,155.27406,278,490.582,547,217,502.791,724,433,459.02
净利润865,800,086.14337,283,020.122,112,264,516.351,427,390,948.39
每股收益
其他综合收益--19,095,716.1419,095,716.14
综合收益总额865,800,086.14337,283,020.122,131,360,232.491,446,486,664.53
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,265,558,876.448,054,263,131.797,722,300,180.618,542,146,987.56
非流动资产:
非流动资产合计8,256,258,173.318,181,080,667.838,147,222,036.957,011,473,702.28
资产总计16,521,817,049.7516,235,343,799.6215,869,522,217.5615,553,620,689.84
流动负债:
流动负债合计1,293,239,592.011,120,502,082.121,120,345,416.741,551,377,773.57
非流动负债:
非流动负债合计238,439,458.81244,360,116.76215,978,220.2153,643,369.74
负债合计1,531,679,050.821,364,862,198.881,336,323,636.941,705,021,143.31
所有者权益(或股东权益):
归属于母公司股东权益合计11,573,529,356.3111,382,850,030.2611,138,704,354.8110,641,258,989.42
股东权益合计14,990,137,998.9314,870,481,600.7414,533,198,580.6213,848,599,546.53
负债和股东权益合计16,521,817,049.7516,235,343,799.6215,869,522,217.5615,553,620,689.84
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,786,497,499.46703,003,919.445,065,423,421.854,126,168,008.53
经营活动现金流出小计1,988,402,049.581,004,643,632.644,245,642,716.762,827,416,229.03
经营活动产生的现金流量净额-201,904,550.12-301,639,713.2819,780,705.091,298,751,779.5
投资活动产生的现金流量:
投资活动现金流入小计737,180,887.6652,446.71,046,990,249.31,046,963,037
投资活动现金流出小计325,460,519.56144,405,613.982,906,106,439.811,271,439,118.78
投资活动产生的现金流量净额411,720,368.1-144,353,167.28-1,859,116,190.51-224,476,081.78
筹资活动产生的现金流量:
筹资活动现金流入小计42,137,862.6334,737,094.71--
筹资活动现金流出小计315,178,569.812,068,648.47370,286,842.87366,301,042.97
筹资活动产生的现金流量净额-273,040,707.1832,668,446.24-370,286,842.87-366,301,042.97
汇率变动对现金及现金等价物的影响-2,279.48370.01-43,795.73-62,388.04
现金及现金等价物净增加额-63,227,168.68-413,324,064.23-1,409,666,124.02707,912,266.71
期末现金及现金等价物余额1,359,693,736.361,009,596,840.811,422,920,905.043,540,499,295.77
补充资料:
现金及现金等价物的净增加额-63,227,168.68--1,409,666,124.02-
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,黄翰漾0.690.851.002025-09-11
中信证券陈竹,王凯旋,韩世通0.800.901.072025-09-10
申万宏源凌静怡0.790.880.982025-08-28
开源证券阮帅,余汝意0.881.111.262025-08-27
中国银河程培,宋丽莹0.760.881.012025-08-27
TOP↑